Evaluation of Anti-anxiety activity of Azadirachta indica and Ocimum sanctum leaves in Rats

Abstract

"Anxiety Disorders Association of America (ADAA)" stated anxiety
disorder is the most common mental illness in the U.S.A. with 13.3%
(19.1 million) of the adult population (ages 18-54) being affected.
Anxiety disorders cause costs of more than $42 billion a year, almost one
third of the $148 billion total mental health bill for U.S.A. Animal
models of anxiety have been used in psychopharmacology typically in
relative to the achievement or malfunction of a given model in predicting
the clinical anxiolytic potency of pharmacological agents. The present
paper deals with evaluation of anti-anxiety activity of A. indica & O.
sanctum leaves.